Verition Fund Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
Other funds holding GWPH
Verition Fund Management's GWPH Position: Q2 2021 in Review
Verition Fund Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 99,475 shares — an estimated $21.6M sold.
Verition Fund Management first reported a position in GWPH in Q2 2018 and held it in 6 quarters. The position peaked at $21.6M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Verition Fund Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Verition Fund Management sold 99,475 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $21.6M.
- Verition Fund Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2018 and held it in 6 quarters.
- Verition Fund Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $21.6M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Verition Fund Management's 13F filing for Q2 2021, filed 16 Aug 2021.